These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32328599)

  • 21. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting fragment binding poses using a combined MCSS MM-GBSA approach.
    Haider MK; Bertrand HO; Hubbard RE
    J Chem Inf Model; 2011 May; 51(5):1092-105. PubMed ID: 21528911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein-protein binding free energies and re-rank binding poses generated by protein-protein docking.
    Chen F; Liu H; Sun H; Pan P; Li Y; Li D; Hou T
    Phys Chem Chem Phys; 2016 Aug; 18(32):22129-39. PubMed ID: 27444142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calculate protein-ligand binding affinities with the extended linear interaction energy method: application on the Cathepsin S set in the D3R Grand Challenge 3.
    He X; Man VH; Ji B; Xie XQ; Wang J
    J Comput Aided Mol Des; 2019 Jan; 33(1):105-117. PubMed ID: 30218199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. farPPI: a webserver for accurate prediction of protein-ligand binding structures for small-molecule PPI inhibitors by MM/PB(GB)SA methods.
    Wang Z; Wang X; Li Y; Lei T; Wang E; Li D; Kang Y; Zhu F; Hou T
    Bioinformatics; 2019 May; 35(10):1777-1779. PubMed ID: 30329012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of sodium glucose co-transporter 2 (SGLT2) inhibitors with novel structure by molecular docking and dynamics simulation.
    Feng R; Dong L; Wang L; Xu Y; Lu H; Zhang J
    J Mol Model; 2019 Jun; 25(6):175. PubMed ID: 31154518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticancer molecules targeting fibroblast growth factor receptors.
    Liang G; Liu Z; Wu J; Cai Y; Li X
    Trends Pharmacol Sci; 2012 Oct; 33(10):531-41. PubMed ID: 22884522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Docking covalent inhibitors: a parameter free approach to pose prediction and scoring.
    Zhu K; Borrelli KW; Greenwood JR; Day T; Abel R; Farid RS; Harder E
    J Chem Inf Model; 2014 Jul; 54(7):1932-40. PubMed ID: 24916536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thalidomide and Its Analogs Differentially Target Fibroblast Growth Factor Receptors: Thalidomide Suppresses FGFR Gene Expression while Pomalidomide Dampens FGFR2 Activity.
    Sundaresan L; Kumar P; Manivannan J; Balaguru UM; Kasiviswanathan D; Veeriah V; Anishetty S; Chatterjee S
    Chem Res Toxicol; 2019 Apr; 32(4):589-602. PubMed ID: 30834740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations.
    Dong L; Feng R; Bi J; Shen S; Lu H; Zhang J
    J Mol Model; 2018 Mar; 24(4):86. PubMed ID: 29511885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular dynamics investigation on a series of HIV protease inhibitors: assessing the performance of MM-PBSA and MM-GBSA approaches.
    Srivastava HK; Sastry GN
    J Chem Inf Model; 2012 Nov; 52(11):3088-98. PubMed ID: 23121465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring.
    Sun H; Li Y; Shen M; Tian S; Xu L; Pan P; Guan Y; Hou T
    Phys Chem Chem Phys; 2014 Oct; 16(40):22035-45. PubMed ID: 25205360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural Characterization of the Interaction of the Fibroblast Growth Factor Receptor with a Small Molecule Allosteric Inhibitor.
    Kappert F; Sreeramulu S; Jonker HRA; Richter C; Rogov VV; Proschak E; Hargittay B; Saxena K; Schwalbe H
    Chemistry; 2018 Jun; 24(31):7861-7865. PubMed ID: 29656465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model Building of Antibody-Antigen Complex Structures Using GBSA Scores.
    Shimba N; Kamiya N; Nakamura H
    J Chem Inf Model; 2016 Oct; 56(10):2005-2012. PubMed ID: 27618247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prioritizing Small Sets of Molecules for Synthesis through in-silico Tools: A Comparison of Common Ranking Methods.
    Breznik M; Ge Y; Bluck JP; Briem H; Hahn DF; Christ CD; Mortier J; Mobley DL; Meier K
    ChemMedChem; 2023 Jan; 18(1):e202200425. PubMed ID: 36240514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations.
    Liu K; Watanabe E; Kokubo H
    J Comput Aided Mol Des; 2017 Feb; 31(2):201-211. PubMed ID: 28074360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular dynamics and MM/GBSA-integrated protocol probing the correlation between biological activities and binding free energies of HIV-1 TAR RNA inhibitors.
    Peddi SR; Sivan SK; Manga V
    J Biomol Struct Dyn; 2018 Feb; 36(2):486-503. PubMed ID: 28081678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM-GBSA calculation.
    Du J; Sun H; Xi L; Li J; Yang Y; Liu H; Yao X
    J Comput Chem; 2011 Oct; 32(13):2800-9. PubMed ID: 21717478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of various electrostatic potentials on docking precision against cyclin-dependent kinase 2 protein: a multiple docking approach.
    Tripathi SK; Soundarya RN; Singh P; Singh SK
    Chem Biol Drug Des; 2015 Feb; 85(2):107-18. PubMed ID: 24923208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probing Origin of Binding Difference of inhibitors to MDM2 and MDMX by Polarizable Molecular Dynamics Simulation and QM/MM-GBSA Calculation.
    Chen J; Wang J; Zhang Q; Chen K; Zhu W
    Sci Rep; 2015 Nov; 5():17421. PubMed ID: 26616018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.